DRUG DIFFERENTIATION BY DESIGN Trademark

Trademark Overview

On Thursday, December 15, 2016, a trademark application was filed for DRUG DIFFERENTIATION BY DESIGN with the United States Patent and Trademark Office. The USPTO has given the DRUG DIFFERENTIATION BY DESIGN trademark a serial number of 87269501. The federal status of this trademark filing is REGISTERED as of Tuesday, October 6, 2020. This trademark is owned by MonoSol RX, LLC. The DRUG DIFFERENTIATION BY DESIGN trademark is filed in the Computer & Software Services & Scientific Services category with the following description:

Research and development of pharmaceutical preparations and medicines; Conducting early evaluations in the field of new pharmaceuticals; Medical and scientific research in the fields of pharmaceuticals, medicine, and therapeutics; Consulting services in the fields of pharmaceutical research and development
drug differentiation by design

General Information

Serial Number87269501
Word MarkDRUG DIFFERENTIATION BY DESIGN
Filing DateThursday, December 15, 2016
Status700 - REGISTERED
Status DateTuesday, October 6, 2020
Registration Number6169614
Registration DateTuesday, October 6, 2020
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, June 20, 2017

Trademark Statements

NOT AVAILABLE"DRUG DIFFERENTIATION"
Goods and ServicesResearch and development of pharmaceutical preparations and medicines; Conducting early evaluations in the field of new pharmaceuticals; Medical and scientific research in the fields of pharmaceuticals, medicine, and therapeutics; Consulting services in the fields of pharmaceutical research and development

Classification Information

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateWednesday, December 21, 2016
Primary Code042
First Use Anywhere DateThursday, August 13, 2020
First Use In Commerce DateThursday, August 13, 2020

Trademark Owner History

Party NameAQUESTIVE THERAPEUTICS, INC.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressWarren, NJ 07059
Party NameAQUESTIVE THERAPEUTICS, INC.
Party Type21 - New Owner After Publication
Legal Entity Type03 - Corporation
AddressWARREN, NJ 07059
Party NameMonoSol RX, LLC
Party Type20 - Owner at Publication
Legal Entity Type16 - Limited Liability Company
AddressWarren, NJ 07059
Party NameMonoSol RX, LLC
Party Type10 - Original Applicant
Legal Entity Type16 - Limited Liability Company
AddressWarren, NJ 07059

Trademark Events

Event DateEvent Description
Wednesday, March 22, 2017NON-FINAL ACTION WRITTEN
Monday, December 19, 2016NEW APPLICATION ENTERED
Wednesday, December 21, 2016NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Friday, March 17, 2017ASSIGNED TO EXAMINER
Wednesday, March 22, 2017NON-FINAL ACTION E-MAILED
Wednesday, March 22, 2017NOTIFICATION OF NON-FINAL ACTION E-MAILED
Friday, April 21, 2017TEAS RESPONSE TO OFFICE ACTION RECEIVED
Friday, April 21, 2017CORRESPONDENCE RECEIVED IN LAW OFFICE
Saturday, April 22, 2017TEAS/EMAIL CORRESPONDENCE ENTERED
Friday, May 12, 2017APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, May 31, 2017NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, June 20, 2017PUBLISHED FOR OPPOSITION
Tuesday, June 20, 2017OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, August 15, 2017NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Wednesday, January 31, 2018AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Wednesday, February 7, 2018SOU TEAS EXTENSION RECEIVED
Wednesday, February 7, 2018SOU EXTENSION 1 FILED
Wednesday, February 7, 2018SOU EXTENSION 1 GRANTED
Friday, February 9, 2018NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, July 18, 2018NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, July 16, 2018SOU TEAS EXTENSION RECEIVED
Monday, July 16, 2018SOU EXTENSION 2 FILED
Monday, July 16, 2018SOU EXTENSION 2 GRANTED
Monday, February 11, 2019SOU TEAS EXTENSION RECEIVED
Monday, February 11, 2019SOU EXTENSION 3 FILED
Monday, February 11, 2019SOU EXTENSION 3 GRANTED
Wednesday, February 13, 2019NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, August 14, 2019SOU TEAS EXTENSION RECEIVED
Wednesday, August 14, 2019SOU EXTENSION 4 FILED
Wednesday, August 14, 2019SOU EXTENSION 4 GRANTED
Friday, August 16, 2019NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, February 18, 2020SOU TEAS EXTENSION RECEIVED
Tuesday, February 18, 2020SOU EXTENSION 5 FILED
Wednesday, February 26, 2020CASE ASSIGNED TO INTENT TO USE PARALEGAL
Thursday, February 27, 2020SOU EXTENSION 5 GRANTED
Thursday, February 27, 2020APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Thursday, September 3, 2020NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Tuesday, October 6, 2020REGISTERED-PRINCIPAL REGISTER
Thursday, August 25, 2022TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Friday, February 28, 2020NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, August 14, 2020TEAS STATEMENT OF USE RECEIVED
Friday, August 14, 2020USE AMENDMENT FILED
Tuesday, August 25, 2020STATEMENT OF USE PROCESSING COMPLETE
Wednesday, September 2, 2020ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Thursday, August 25, 2022TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
Thursday, August 25, 2022ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Thursday, August 25, 2022TEAS CHANGE OF CORRESPONDENCE RECEIVED
Friday, July 26, 2024TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Friday, July 26, 2024TEAS CHANGE OF OWNER ADDRESS RECEIVED
Friday, July 26, 2024ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Friday, July 26, 2024TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
Friday, July 26, 2024APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Friday, July 26, 2024TEAS CHANGE OF CORRESPONDENCE RECEIVED
Monday, October 6, 2025COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED

Related Keywords

design differentiation drug research fields pharmaceuticals pharmaceutical development medicine consulting services scientific therapeutics